메뉴 건너뛰기




Volumn 15, Issue 1, 2017, Pages 74-79

Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice

Author keywords

cancer; low molecular weight heparin; patient adherence; patient compliance; venous thromboembolism

Indexed keywords

ENOXAPARIN; NADROPARIN; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

EID: 85007488752     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13563     Document Type: Article
Times cited : (46)

References (20)
  • 1
    • 34247568441 scopus 로고    scopus 로고
    • Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
    • Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007; 5: 632–4.
    • (2007) J Thromb Haemost , vol.5 , pp. 632-634
    • Khorana, A.A.1    Francis, C.W.2    Culakova, E.3    Kuderer, N.M.4    Lyman, G.H.5
  • 2
    • 0038718518 scopus 로고    scopus 로고
    • Venous thromboembolism and cancer: risks and outcomes
    • Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003; 107: I17–21.
    • (2003) Circulation , vol.107 , pp. I17-21
    • Lee, A.Y.1    Levine, M.N.2
  • 3
    • 13444256137 scopus 로고    scopus 로고
    • Malignancies, prothrombotic mutations, and the risk of venous thrombosis
    • Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715–22.
    • (2005) JAMA , vol.293 , pp. 715-722
    • Blom, J.W.1    Doggen, C.J.2    Osanto, S.3    Rosendaal, F.R.4
  • 5
    • 84940649946 scopus 로고    scopus 로고
    • Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial
    • Lee AY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, Khorana AA. Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial. JAMA 2015; 314: 677–86.
    • (2015) JAMA , vol.314 , pp. 677-686
    • Lee, A.Y.1    Kamphuisen, P.W.2    Meyer, G.3    Bauersachs, R.4    Janas, M.S.5    Jarner, M.F.6    Khorana, A.A.7
  • 7
    • 0030184305 scopus 로고    scopus 로고
    • Effect of syringe size on bruising following subcutaneous heparin injection
    • Hadley SA, Chang M, Rogers K. Effect of syringe size on bruising following subcutaneous heparin injection. Am J Crit Care 1996; 5: 271–6.
    • (1996) Am J Crit Care , vol.5 , pp. 271-276
    • Hadley, S.A.1    Chang, M.2    Rogers, K.3
  • 9
    • 33748498896 scopus 로고    scopus 로고
    • Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
    • Deitcher SR, Kessler CM, Merli G, Rigas JR, Lyons RM, Fareed J. Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period. Clin Appl Thromb Hemost 2006; 12: 389–96.
    • (2006) Clin Appl Thromb Hemost , vol.12 , pp. 389-396
    • Deitcher, S.R.1    Kessler, C.M.2    Merli, G.3    Rigas, J.R.4    Lyons, R.M.5    Fareed, J.6
  • 12
    • 84928499067 scopus 로고    scopus 로고
    • Treatment of venous thromboembolism in ambulatory cancer patients in Germany: a prospective non-interventional study
    • Matzdorff A, Schilling H, Ledig B. Treatment of venous thromboembolism in ambulatory cancer patients in Germany: a prospective non-interventional study. Oncol Res Treat 2015; 38: 174–80.
    • (2015) Oncol Res Treat , vol.38 , pp. 174-180
    • Matzdorff, A.1    Schilling, H.2    Ledig, B.3
  • 13
    • 84875263410 scopus 로고    scopus 로고
    • Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study
    • Rahme E, Feugere G, Sirois C, Weicker S, Ramos E. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study. Thromb Res 2013; 131: 210–17.
    • (2013) Thromb Res , vol.131 , pp. 210-217
    • Rahme, E.1    Feugere, G.2    Sirois, C.3    Weicker, S.4    Ramos, E.5
  • 14
    • 84904335836 scopus 로고    scopus 로고
    • Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism
    • van der Hulle T, den Exter PL, Kooiman J, van der Hoeven JJ, Huisman MV, Klok FA. Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism. J Thromb Haemost 2014; 12: 1116–20.
    • (2014) J Thromb Haemost , vol.12 , pp. 1116-1120
    • van der Hulle, T.1    den Exter, P.L.2    Kooiman, J.3    van der Hoeven, J.J.4    Huisman, M.V.5    Klok, F.A.6
  • 15
    • 84874965931 scopus 로고    scopus 로고
    • Diagnostic management of acute deep vein thrombosis and pulmonary embolism
    • Huisman MV, Klok FA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism. J Thromb Haemost 2013; 11: 412–22.
    • (2013) J Thromb Haemost , vol.11 , pp. 412-422
    • Huisman, M.V.1    Klok, F.A.2
  • 16
    • 23044505564 scopus 로고    scopus 로고
    • Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
    • Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692–4.
    • (2005) J Thromb Haemost , vol.3 , pp. 692-694
    • Schulman, S.1    Kearon, C.2
  • 17
    • 84923821726 scopus 로고    scopus 로고
    • Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality
    • Ay C, Posch F, Kaider A, Zielinski C, Pabinger I. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality. J Thromb Haemost 2015; 13: 390–7.
    • (2015) J Thromb Haemost , vol.13 , pp. 390-397
    • Ay, C.1    Posch, F.2    Kaider, A.3    Zielinski, C.4    Pabinger, I.5
  • 18
    • 84896741977 scopus 로고    scopus 로고
    • Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis
    • van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 2014; 12: 320–8.
    • (2014) J Thromb Haemost , vol.12 , pp. 320-328
    • van der Hulle, T.1    Kooiman, J.2    den Exter, P.L.3    Dekkers, O.M.4    Klok, F.A.5    Huisman, M.V.6
  • 19
    • 84893418928 scopus 로고    scopus 로고
    • Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants
    • Wharin C, Tagalakis V. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants. Blood Rev 2014; 28: 1–8.
    • (2014) Blood Rev , vol.28 , pp. 1-8
    • Wharin, C.1    Tagalakis, V.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.